Navigating Nanosatellite And Microsatellite Market: A Study of the Industry's Key Segments Read More: https://www.emergenresearch.com/industry-report/nanosatellite-and-microsatellite-market The global nanosatellite and microsatellite market size is expected to reach USD 7.13 Billion at a steady CAGR of 19.8% in 2028, according to latest analysis by Emergen Research. Increasing demand for improved communications and services and growing traction of Internet of Things are some key factors driving growth of the global nanosatellite and microsatellite market. Nanosatellite and microsatellite launches are low-risk and have a high success rate. Satellite launches are carried out by government agencies, private companies, as well as others.

In-Vitro Diagnostics Market: A Look at the Industry's Advancements and Opportunities Read More: https://www.emergenresearch.com/industry-report/in-vitro-diagnostics-market The global In-Vitro Diagnostics (IVD) market size is expected to reach USD 118.44 Billion at a steady revenue CAGR of 4.4% in 2028, according to latest analysis by Emergen Research. In-vitro diagnostics market revenue growth is due to increased investment in research & development in genomics and proteomics, and rising prevalence of targeted diseases. Rapid increase in geriatric population globally, rising prevalence of sedentary lifestyle-related diseases and conditions, and rise in infectious diseases rates are other factors driving revenue growth of the global market. Increase in prevalence of targeted diseases such as gastrointestinal diseases, diabetes, cardiac disorders, and cancer, is also contributing positively to global in-vitro diagnostic market revenue growth. According to International Diabetes Federation (IDF), 463 million people suffer from diabetes globally. Just over 1 in 10 Americans have diabetes and continuous increase in this number is driving demand for IVD products for rapid testing.

The Fuel Cells Revolution: A Market Overview Read More: https://www.emergenresearch.com/industry-report/fuel-cells-market The global fuel cell market size reached USD 4.26 Billion in 2021 and is expected to register a revenue CAGR of 22.8% during the forecast period, according to latest analysis by Emergen Research. Rising adoption of fuel cells in military applications across the globe is the key factor driving revenue growth of the market. Fuel cells are becoming an attractive option for military applications. Its ability to generate clean, reliable electricity from hydrogen on-site is being used in a variety of ways to assist soldiers in protecting national security while also improving energy efficiency.

Intelligent Transportation System Market: From Research to Real-World Applications Read More: https://www.emergenresearch.com/industry-report/intelligent-transportation-system-market The global Intelligent Transportation System (ITS) Market is expected to reach USD 48.17 Billion by 2027, according to a new report by Emergen Research. The increasing number of on-road vehicles and inefficient existing transport infrastructure will encourage the need for an intelligent transportation system. Actions by the government towards establishing a more reliable infrastructure and running the transport system easily are anticipated to grow the market globally.

The bacteriophage therapeutics market is anticipated to grow at a CAGR of 10%, till 2035, claims Roots Analysis Given the low toxicity, specific targeting and ability to offer higher biosafety, the bacteriophage therapeutics are actively being evaluated for the treatment of various infectious diseases London Roots Analysis has announced the addition of “Bacteriophage Therapeutics Market, 2022-2035” report to its list of offerings. With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases. One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains. With the growing need for therapies targeting AMR infections, bacteriophage therapy is now gaining more traction. Key Market Insights Close to 15 bacteriophage therapeutics are commercialized, while more than 90 are currently at different stages of development Close to 50% of the pipeline candidates are under clinical evaluation; majority (91%) of these candidates are being developed for the treatment of infectious diseases, targeting wide range of bacterial strains. 40+ industry stakeholders claim to have the required capability to manufacture bacteriophage therapeutics The bacteriophage therapy market is currently dominated by the presence of various small players (48%); of these 55% of the players are located in North America, followed by Europe (35%). More than 2,200 articles focused on bacteriophage therapeutics have been published, since 2018 Around 40% of these were published in the last two years, indicating the extensive research activity being carried out in this domain. Close to USD 1,200 million has been invested by both private and public investors, since 2017 Of the total amount invested, over USD 330 million was raised through venture capital funding, representing close to 30% of the overall funding activity in this domain. Further, close to 40% of the instances were, wherein players were collectively awarded more than USD 300 million. Partnership activity within this domain has grown significantly between the time period, 2017-2021 Maximum number of partnerships were established in 2021, indicating a recent rise in the interest of players engaged in this domain. It is worth highlighting that, majority of the deals were related to the research and development (20%), followed by agreements signed for product development (15%). More than 3,500 patients have been enrolled in over 40 clinical trials, worldwide Clinical research activity, in terms of number of trials registered, is reported to has significantly increased in the past few years. Of the total number of trials, close to 35% have already been completed, while 41% are active and still recruiting patients. Europe are anticipated to capture larger share (~95%) of the market by 2035 Currently, in bacteriophage therapeutics market, gastrointestinal infections capture the highest share (~50%) and this trend is unlikely to change in the foreseen future. Further, more than 55% share of the market is captured by oral bacteriophage therapeutics. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market/request-sample.html Key Questions Answered  Which bacteriophage therapeutics candidates are currently under clinical stage of development pipeline?  Who are the leading players engaged in the development of bacteriophage therapeutics?  Which geographies are the most active in conducting clinical trials related to bacteriophage therapeutics?  What is the focus of various publications related to bacteriophage therapeutics?  Which partnership models are commonly adopted by industry and non-industry stakeholders?  What are the investment trends in the industry?  What are the different initiatives undertaken by start-ups for the development of bacteriophage therapeutics in the recent past?  How is the current and future market opportunity likely to be distributed across key market segments? The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:  Type of Therapeutic Area  Gastrointestinal Infections  Bacterial Dysentery  Multiple Infections  Other Infections  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The report features inputs from eminent industry stakeholders, according to whom upcoming generations of bacteriophage therapeutics are likely to garner significant interest among therapy developers and end users alike. The report includes detailed transcripts of discussions held with the following experts:  Antoine Culot (Chief Executive Officer, Rime Bioinformatics)  Mathieu Medina (Project Leader, Hospices Civils De Lyon)  Iddo Weiner (Senior Director, Head of Data-Science, BiomX)  Mohammadreza Azizkhani (Independent Consultant) The research also includes detailed profiles of key players (listed below), featuring an overview of the company, its financial information (if available), detailed information on the advanced stage pipeline candidates and an informed future outlook.  Adaptive Phage Therapeutics  ContaFect  Eliava BioPreparations  Micreos  NPO Microgen  Phagelux  Pherecydes Pharma For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

Navigating Injectable Drug Delivery Market: A Study of the Industry's Key Segments Read More: https://www.emergenresearch.com/industry-report/injectable-drug-delivery-market The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to latest analysis by Emergen Research. Injectable drug delivery market revenue growth is owing to a rising trend of pre-filled syringes along with technological developments.

Biofuels Market: A Study of the Current Status and Future Prospects Read More: https://www.emergenresearch.com/industry-report/biofuels-market The global biofuels market size reached USD 154.76 Billion in 2021 and is expected to register a revenue CAGR of 7.0% during the forecast period, according to the latest analysis by Emergen Research. Biofuels burn cleaner than gasoline and result in low carbon emissions, therefore, their use in transport results in fewer greenhouse gas emissions. This factor is driving biofuel market revenue growth.

Carbon Nanotubess Market: A Study of the Key Applications and Technologies The global Carbon Nanotube (CNT) market size reached USD 876.8 Million in 2021 and is expected to register a revenue CAGR of 14.9% during the forecast period, according to latest analysis by Emergen Research. Increasing application of Carbon Nanotubes (CNTs) in the healthcare sector is expected to support market revenue growth between 2021 and 2030. Read More: https://www.emergenresearch.com/industry-report/carbon-nanotube-market CNTs are nanomaterials widely used in nanotechnology, from materials and electronics to nanomedicine, and they play an important role in innovation of nanomaterials for next-generation theranostic nanomedicine. Biosensors made with CNT can diagnose yeast infection more quickly than the current method, while targeting tumors is another possible medical application of CNTs. CNTs have already reached consumers through a variety of marketed products, ranging from batteries to sporting goods, and they are going to be used as an alternative to silicon in next-generation of nanoscale processors.

https://www.bewindia.co/product/zero-seed-drill/

The rise and challenges associated with development and testing of combination products In the recent years, pharmaceutical developers have been engaged in the development of devices that can combine the drug and its drug delivery device, for delivering pharmaceutical drugs efficiently, as well as enable higher patient compliance rates. These products, commonly referred to as combination products, have made a tremendous impact on the healthcare landscape in recent years, given their potential for significant therapeutic advantages over conventional dosage forms, maintaining dosage compliance, thereby improving patient experience. In simpler terms, a combination product can be defined as a product which is composed of two or more pharmacological products. A combination product is comprised of two or more regulated components – drug / device, drug / biologic, or drug / device / biologic. Each drug, device, and biologic included in a combination product is referred to as a constituent part of the combination product. According to the United States Food and Drug Administration (USFDA), a combination product can be classified based on its constituent parts. The combination product services market is likely to witness a significant growth in the coming years. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/combination-product-services-market/request-sample.html However, development and testing of combination products is a highly complex process, fraught with multiple of challenges, such as need for advanced technologies, consistent drug volume, multiple interactions between the drug and the device, and safety and efficacy-related issues. Given the growing demand for combination products and technical complexities associated with the manufacturing of such products, developers are increasingly relying on organizations that can provide services related to development and testing of combination products. As highlighted above, there are various types of combination products and manufacturing platforms / technologies available for their production. The methods for manufacturing such complex products are usually associated with high degrees of complexity. It is worth mentioning that several contract organizations, across the globe offer a wide range of services to cater to the development / testing needs of various pharmaceutical companies. The presence of such organizations has significantly reduced commercial risk and deployment of capital to develop in-house facilities. According to our proprietary scoring criteria, very small / small - prefilled syringe combination product developers, are likely to have high value addition on outsourcing their product development and testing operations. The drug device combination product is used for delivery of biologics via the subcutaneous route. Given the challenges associated with the development of combination products has increased the extent of outsourcing activity in this domain. Numerous service providers with varying strengths and capabilities, are contributing actively in the testing / development of the device constituent and / or the finished product. Driven by the growing demand for such advanced medical products, expanding existing capabilities and augmenting efforts to develop, test and pack combination products and contributions of several big pharma players. this market is anticipated to witness tremendous growth in the coming years. For more information, please click on the following link: https://www.rootsanalysis.com/reports/combination-product-services-market.html You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com